US Drug Recall Register

FDA Drug Recalls

1,739 recalls · Class I, newest first

Class I · High risk Terminated

BD ChloraPrep Clear

Reason Non-sterility.Product is being recalled because at labeled storage conditions of 30*C/75% Relative Humidity, growth of Aspergillus penicillioides, a type of fungus, resulted in a breach of the package integrity.

CareFusion 213, LLC NDC 54365-400-32 D-0343-2021
Class I · High risk Terminated

Telmisartan Tablets

Reason Labeling: Label-mixup

Alembic Pharmaceuticals Limited NDC 62332-087-30 D-0326-2021
Class I · High risk Terminated

Durisan Antimicrobial Solutions

Reason Microbial Contamination of Non-Sterile Products: firm's internal testing found certain lots of the product to be contaminated with Burkholderia contaminans and/or yeast and mold.

Sanit Technologies, LLC dba Durisan D-0657-2021
Class I · High risk Terminated

Durisan Antimicrobial Solutions

Reason Microbial Contamination of Non-Sterile Products: firm's internal testing found certain lots of the product to be contaminated with Burkholderia contaminans and/or yeast and mold.

Sanit Technologies, LLC dba Durisan D-0656-2021
Class I · High risk Terminated

heal the world

Reason Labeling Not Elsewhere Classified: Hand sanitizer packaged in containers resembling drinking water bottles.

Pnhc, LLC. D-0365-2021
Class I · High risk Terminated

Acetaminophen

Reason Labeling: Label Mix-up; The bottle of over-the-counter Acetaminophen 500mg Extra Strength, 100 count, included in Health Essential Kits, labeled incorrectly with a prescription drug label instead of an OTC drug label.

A-S Medication Solutions LLC. D-0358-2021
Class I · High risk Terminated

Acyclovir Sodium Injection 500mg/10mL

Reason Crystallization: customer complaints for crystallization in finished product.

Zydus Pharmaceuticals (USA) Inc NDC 68382-048-01 D-0316-2021
Class I · High risk Terminated

Acyclovir Sodium Injection 1000mg/20mL

Reason Crystallization: customer complaints for crystallization in finished product.

Zydus Pharmaceuticals (USA) Inc NDC 68382-049-01 D-0315-2021
Class I · High risk Terminated

Adam's Secret Extra Strength 3000

Reason Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil and sildenafil.

Adams.Secret.co D-0311-2021
Class I · High risk Terminated

Adam's Secret Extra Strength 1500

Reason Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil and sildenafil.

Adams.Secret.co D-0310-2021
Class I · High risk Ongoing

Enoxaparin Sodium Injection

Reason Labeling; Label Mixup; syringe barrels may contain markings for 100 mg/mL (corresponding to 100 mg/mL strength) instead of 150 mg/mL (corresponding to 120 mg/0.8mL strength)

Apotex Corp. NDC 60505-0796-4 D-0262-2021
Class I · High risk Ongoing

Enoxaparin Sodium Injection

Reason Labeling; Label Mixup; syringe barrels may containing markings for 150 mg/mL (corresponding to 120 mg/0.8mL strength) instead of 100 mg/mL markings (corresponding to 100 mg/mL strength)

Apotex Corp. NDC 60505-0795-4 D-0261-2021
Class I · High risk Ongoing

Spironolactone Tablets

Reason Labeling: Label Mix-Up - Prepackaged bottles labeled spironolactone 25 mg may contain spironolactone 50 mg tablets.

Bryant Ranch Prepack, Inc. dba BRP Pharmaceuticals NDC 63629-1064-01 D-0303-2021
Class I · High risk Terminated

Cisatracurium Besylate Injection

Reason Labeling: Label mix-up: Carton of Cisatracurium Besylate Injection, USP was observed to contain ten vials mislabeled as Phenylephrine Hydrochloride Injection, USP, but confirmed to contain Cisatracurium

Meitheal Pharmaceuticals Inc NDC 71288-712-05 D-0286-2021
Class I · High risk Terminated

Benzonatate capsules

Reason Labeling: Label Mix-up: Bottle labeled as Benzonatate 100 mg capsules contained Benzphetamine 50 mg tablets and a bottle labeled as Benzphetamine 50 mg tablets contained Benzonatate 100 mg capsules.

Calvin Scott & Company, Inc. NDC 67877-0573-05 D-1124-2022
Class I · High risk Terminated

Ketorolac Tromethamine Injection

Reason Presence of Particulate Matter - found in reserve sample vials at the firm.

Fresenius Kabi USA, LLC NDC 63323-162-00 D-0245-2021
Class I · High risk Terminated

TraZODONE Hydrochloride Tablets USP 100 mg

Reason Product mix-up: Bottles of sildenafil and trazodone were inadvertently packaged together during bottling at a 3rd party facility.

AVKARE Inc. NDC 42291-834-10 D-0168-2021
Class I · High risk Terminated

Anagrelide Capsules

Reason Failed Dissolution Specifications

Torrent Pharma Inc NDC 13668-462-01 D-0166-2021
Class I · High risk Terminated

Regenecare Ha

Reason Microbial Contamination of Non-Sterile Drug Product. The product was found to be contaminated with the bacteria Burkholderia cepecia.

MPM Medical LLC NDC 66977-107-03 D-0118-2021
Class I · High risk Terminated

Chlorhexidine Gluconate Oral Rinse USP

Reason Microbial contamination of non-sterile products: Repackaged product was recalled by manufacturer because it was contaminated with the bacteria Burkholderia lata.

Lohxa LLC NDC 70166-027-15 D-0111-2021
Class I · High risk Completed

Paroex

Reason Microbial Contamination of Non-sterile Products: contamination with Burkholderia lata.

Sunstar Americas, Inc. NDC 52376-021-02 D-0103-2021